Investor Relations

OPKO and Bio-Reference Laboratories Announce Early Termination of the Waiting Period for Planned Acquisition more »

Conversion Right Extended on OPKO 3.0% Convertible Senior Notes more »

OPKO 4Kscore® Recommended in National Comprehensive Cancer Network Guidelines for Prostate Cancer Early Detection more »

OPKO to Present New Data at International Society on Thrombosis and Haemostasis (ISTH) 2015 Congress on Its Long-Acting Clotting Factor VIIa more »

Investor Relations

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put OPKO Health, Inc.'s financial performance into perspective.

  • Events


  • Stock Information


Ticker OPK Exchange NYSE
Last Price 16.25 Change 0.02 down
Open 16.33 Previous Close 16.27
Day High 16.35 Day Low 16.01
52-Week High 19.20 52-Week Low 8.02
Quotes delayed at least 20 minutes. Information provided by eSignal.